Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - New York Stock Exchange, Inc. - US1844961078 - Common Stock - Currency: USD

218.01  +5.83 (+2.75%)

After market: 218.01 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLH. CLH was compared to 84 industry peers in the Commercial Services & Supplies industry. CLH has an average financial health and profitability rating. CLH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CLH had positive earnings in the past year.
In the past year CLH had a positive cash flow from operations.
Of the past 5 years CLH 4 years were profitable.
Of the past 5 years CLH 4 years had a positive operating cash flow.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.70%, CLH is in the better half of the industry, outperforming 69.51% of the companies in the same industry.
CLH has a Return On Equity of 16.48%. This is in the better half of the industry: CLH outperforms 79.27% of its industry peers.
CLH has a better Return On Invested Capital (8.34%) than 68.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLH is below the industry average of 10.12%.
The last Return On Invested Capital (8.34%) for CLH is above the 3 year average (7.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.7%
ROE 16.48%
ROIC 8.34%
ROA(3y)5.41%
ROA(5y)4.37%
ROE(3y)17.22%
ROE(5y)13.88%
ROIC(3y)7.88%
ROIC(5y)6.79%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 7.19%, CLH is doing good in the industry, outperforming 76.83% of the companies in the same industry.
In the last couple of years the Profit Margin of CLH has grown nicely.
Looking at the Operating Margin, with a value of 11.74%, CLH is in the better half of the industry, outperforming 74.39% of the companies in the same industry.
In the last couple of years the Operating Margin of CLH has grown nicely.
Looking at the Gross Margin, with a value of 31.25%, CLH is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CLH has remained more or less at the same level.
Industry RankSector Rank
OM 11.74%
PM (TTM) 7.19%
GM 31.25%
OM growth 3Y14.33%
OM growth 5Y15.4%
PM growth 3Y17.67%
PM growth 5Y28.58%
GM growth 3Y-1.33%
GM growth 5Y0.4%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

CLH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CLH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.18. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
CLH's Altman-Z score of 3.18 is fine compared to the rest of the industry. CLH outperforms 68.29% of its industry peers.
CLH has a debt to FCF ratio of 10.38. This is a negative value and a sign of low solvency as CLH would need 10.38 years to pay back of all of its debts.
CLH has a Debt to FCF ratio of 10.38. This is comparable to the rest of the industry: CLH outperforms 52.44% of its industry peers.
CLH has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
CLH has a worse Debt to Equity ratio (1.10) than 67.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 10.38
Altman-Z 3.18
ROIC/WACC1.02
WACC8.16%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CLH has a Current Ratio of 2.10. This indicates that CLH is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.10, CLH is doing good in the industry, outperforming 75.61% of the companies in the same industry.
A Quick Ratio of 1.76 indicates that CLH should not have too much problems paying its short term obligations.
CLH's Quick ratio of 1.76 is fine compared to the rest of the industry. CLH outperforms 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.76
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

3

3. Growth

3.1 Past

CLH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.15%.
The Earnings Per Share has been growing by 31.46% on average over the past years. This is a very strong growth
EPS 1Y (TTM)6.15%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-14.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.95%

3.2 Future

Based on estimates for the next years, CLH will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.71% on average per year.
The Revenue is expected to grow by 5.89% on average over the next years.
EPS Next Y11.72%
EPS Next 2Y13.41%
EPS Next 3Y14.95%
EPS Next 5Y12.71%
Revenue Next Year5.92%
Revenue Next 2Y5.93%
Revenue Next 3Y5.52%
Revenue Next 5Y5.89%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.38 indicates a quite expensive valuation of CLH.
The rest of the industry has a similar Price/Earnings ratio as CLH.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CLH is valued at the same level.
The Price/Forward Earnings ratio is 26.30, which means the current valuation is very expensive for CLH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLH indicates a somewhat cheap valuation: CLH is cheaper than 60.98% of the companies listed in the same industry.
CLH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.38
Fwd PE 26.3
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CLH's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 43.72
EV/EBITDA 12.61
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CLH may justify a higher PE ratio.
CLH's earnings are expected to grow with 14.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.51
PEG (5Y)0.93
EPS Next 2Y13.41%
EPS Next 3Y14.95%

More info and screens

0

5. Dividend

5.1 Amount

CLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN HARBORS INC

NYSE:CLH (2/21/2025, 8:09:58 PM)

After market: 218.01 0 (0%)

218.01

+5.83 (+2.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners93.69%
Inst Owner Change2.99%
Ins Owners5.87%
Ins Owner Change1.66%
Market Cap11.75B
Analysts83.33
Price Target282 (29.35%)
Short Float %1%
Short Ratio1.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.76%
Min EPS beat(2)-3.86%
Max EPS beat(2)9.37%
EPS beat(4)3
Avg EPS beat(4)5.73%
Min EPS beat(4)-3.86%
Max EPS beat(4)10.7%
EPS beat(8)6
Avg EPS beat(8)2.88%
EPS beat(12)10
Avg EPS beat(12)11.92%
EPS beat(16)14
Avg EPS beat(16)20.48%
Revenue beat(2)2
Avg Revenue beat(2)0.26%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.5%
Revenue beat(4)3
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)1.98%
Revenue beat(8)5
Avg Revenue beat(8)-0.25%
Revenue beat(12)9
Avg Revenue beat(12)2.37%
Revenue beat(16)12
Avg Revenue beat(16)2.5%
PT rev (1m)0.06%
PT rev (3m)3.01%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-0.24%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 29.38
Fwd PE 26.3
P/S 2.03
P/FCF 43.72
P/OCF 15.61
P/B 4.65
P/tB 35.15
EV/EBITDA 12.61
EPS(TTM)7.42
EY3.4%
EPS(NY)8.29
Fwd EY3.8%
FCF(TTM)4.99
FCFY2.29%
OCF(TTM)13.96
OCFY6.41%
SpS107.55
BVpS46.91
TBVpS6.2
PEG (NY)2.51
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 5.7%
ROE 16.48%
ROCE 11%
ROIC 8.34%
ROICexc 9.23%
ROICexgc 15.19%
OM 11.74%
PM (TTM) 7.19%
GM 31.25%
FCFM 4.64%
ROA(3y)5.41%
ROA(5y)4.37%
ROE(3y)17.22%
ROE(5y)13.88%
ROIC(3y)7.88%
ROIC(5y)6.79%
ROICexc(3y)8.83%
ROICexc(5y)7.7%
ROICexgc(3y)15.05%
ROICexgc(5y)12.54%
ROCE(3y)10.39%
ROCE(5y)8.95%
ROICexcg growth 3Y21.2%
ROICexcg growth 5Y17.03%
ROICexc growth 3Y16.18%
ROICexc growth 5Y14.85%
OM growth 3Y14.33%
OM growth 5Y15.4%
PM growth 3Y17.67%
PM growth 5Y28.58%
GM growth 3Y-1.33%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 10.38
Debt/EBITDA 2.58
Cap/Depr 122.83%
Cap/Sales 8.35%
Interest Coverage 4.6
Cash Conversion 70.05%
Profit Quality 64.5%
Current Ratio 2.1
Quick Ratio 1.76
Altman-Z 3.18
F-Score6
WACC8.16%
ROIC/WACC1.02
Cap/Depr(3y)99.48%
Cap/Depr(5y)87.87%
Cap/Sales(3y)7.01%
Cap/Sales(5y)6.76%
Profit Quality(3y)99.18%
Profit Quality(5y)133.48%
High Growth Momentum
Growth
EPS 1Y (TTM)6.15%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-14.84%
EPS Next Y11.72%
EPS Next 2Y13.41%
EPS Next 3Y14.95%
EPS Next 5Y12.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.95%
Revenue Next Year5.92%
Revenue Next 2Y5.93%
Revenue Next 3Y5.52%
Revenue Next 5Y5.89%
EBIT growth 1Y14.84%
EBIT growth 3Y37%
EBIT growth 5Y27.38%
EBIT Next Year76.53%
EBIT Next 3Y28.01%
EBIT Next 5Y20.41%
FCF growth 1Y39.04%
FCF growth 3Y10.05%
FCF growth 5Y12.06%
OCF growth 1Y40.61%
OCF growth 3Y19.49%
OCF growth 5Y14.5%